The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Perioperative ramucirumab in combination with FLOT versus FLOT alone for resectable esophagogastric adenocarcinoma (RAMSES/FLOT7): Results of the phase II-portion—A multicenter, randomized phase II/III trial of the German AIO and Italian GOIM.
 
Salah-Eddin Al-Batran
Stock and Other Ownership Interests - IKF Klinische Krebsforschung
Consulting or Advisory Role - Bristol-Myers Squibb; Celgene; Lilly; Merck; Merck Sharp & Dohme; Nordic Bioscience; Roche
Speakers' Bureau - AIO gGmbH; Celgene; Forum für Medizinische Fortbildung; Lilly; MCI group; Nordic Bioscience
Research Funding - Celgene; Federal Ministry of Education and Research; German Cancer Aid; German Research Foundation; Hospira; Lilly; Medac; Merck; Roche; Sanofi; Vifor Pharma
 
Ralf Dieter Hofheinz
Honoraria - Amgen; Bristol-Myers Squibb; Lilly; Medac; Merck Serono; MSD; Roche; Sanofi
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Merck Serono; MSD; Roche; Sanofi
Speakers' Bureau - Amgen; Bristol-Myers Squibb; Lilly; Merck; MSD; Roche; Sanofi; SERVIER
Research Funding - German Cancer Aid (Inst); Medac (Inst); Sanofi (Inst)
 
Harald Schmalenberg
No Relationships to Disclose
 
Dirk Strumberg
No Relationships to Disclose
 
Eray Goekkurt
Consulting or Advisory Role - Bristol-Myers Squibb; MSD; Roche; Sanofi; SERVIER
 
Stefan Angermeier
No Relationships to Disclose
 
Thomas Zander
Consulting or Advisory Role - Bristol-Myers Squibb; MSD Oncology; Pfizer; Roche
 
Jochem Potenberg
No Relationships to Disclose
 
Hans Georg Kopp
No Relationships to Disclose
 
Daniel Pink
Employment - Helios Kliniken GmbH
Consulting or Advisory Role - Clinigen Group; Lilly; Roche
Research Funding - Clinigen Group; Lilly; Novartis; PharmaMar; Roche
 
Gabriele Margareta Siegler
Honoraria - Eisai; Janssen-Cilag; medizinwelten services GmbH; Roche; Shire
Research Funding - Beigene (Inst); Celgene (Inst); Isofol Medical (Inst); MOLOGEN (Inst); Novartis (Inst); Nutricia (Inst); Roche (Inst); Roche/Genentech (Inst); Sanofi (Inst); Sanofi (Inst); Servier (Inst)
Travel, Accommodations, Expenses - Lilly
 
Michael Schenk
No Relationships to Disclose
 
Ferdinando De Vita
No Relationships to Disclose
 
Evaristo Maiello
No Relationships to Disclose
 
Timo Gaiser
No Relationships to Disclose
 
Disorn Sookthai
No Relationships to Disclose
 
Ulli Simone Bankstahl
No Relationships to Disclose
 
Claudia Pauligk
No Relationships to Disclose
 
Thorsten Oliver Goetze
Consulting or Advisory Role - Bayer; Lilly; MSD Oncology; Roche; SERVIER
Speakers' Bureau - Lilly
Research Funding - Deutsche Forschungsgemeinschaft; Gemeinsamer Bundesausschuss
 
Nils Homann
No Relationships to Disclose